|Articles|November 9, 2021
- Pharmaceutical Executive-11-01-2021
- Volume 41
- Issue 11
Pharmaceutical Executive, November 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 4 years ago
In It For the Long-Haul: Planning for the Future of COVID-19about 4 years ago
Turning the Corner: A New Era of Pharma Sales Comes Into Viewabout 4 years ago
The New COVID Workforce: Keeping Pharma Strong Through Adversityabout 4 years ago
Crafting Curesabout 4 years ago
Could 2022 Prove to Be Better Year for Biotech Companies?about 4 years ago
COVID and the Data Talent Turnaboutabout 4 years ago
Talent Pipelines Can Position Companies for Greater Hiring Successabout 4 years ago
EU MEPs Arrive At Crossroads in Cancer Strategyabout 4 years ago
Pharm Exec at 40 (2015-2018)Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
FDA Announces New Plausible Mechanism Pathway
3
Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates
4
WeightWatchers to Offer Novo Nordisk’s Oral Wegovy, if Approved Next Year
5
